Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wlodarska, I
Right arrow Articles by Cassiman, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wlodarska, I
Right arrow Articles by Cassiman, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

TEL gene is involved in myelodysplastic syndromes with either the typical t(5;12)(q33;p13) translocation or its variant t(10;12)(q24;p13)

I Wlodarska, C Mecucci, P Marynen, C Guo, D Franckx, R La Starza, A Aventin, A Bosly, MF Martelli and JJ Cassiman

Center for Human Genetics, University of Leuven, Belgium.

A t(5;12)(q33;p13) translocation is a recurrent chromosome abnormality in a subgroup of myeloid malignancies with features of both myeloproliferative disorders and myelodysplastic syndromes (MDSs). The molecular consequence of a t(5;12) is a fusion between the platelet- derived growth factor receptor-B gene on chromosome 5 and a novel ETS- like gene, TEL, on chromosome 12. We report on three patients with a t(5;12)(q33;p13) diagnosed as chronic myelomonocytic leukemia, and one case of a t(10;12)(q24;p13) in a progressive MDS, with eosinophilia and monocytosis. Involvement of the TEL gene in these chromosome translocations was investigated by fluorescence in situ hybridization (FISH) with cosmid probes containing selectively the 5' end or 3' end of TEL. Hybridization of these cosmids to the der(5)/der(10) or a der(12), respectively, demonstrated a rearrangement of TEL in both translocations, showing that the t(10;12) is a variant translocation of the t(5;12). Cloning of the fusion cDNA of one case of t(5;12) showed that the breakpoint occurred at the RNA level at exactly the same position as reported by Golub et al (Cell 77:307, 1994). In addition, the TEL gene on chromosome 12 could be localized between two probes previously mapped to 12p13, namely PRB1 and D12S178, leading to a better definition of the position of TEL in this chromosome region. Moreover, in the case involving chromosome 10, the breakpoint occurred between cKTN206 and cKTN312/LYT-10 at 10q24. Clinicohematological data in these studies as well as the restriction mapping of chromosomal breakpoints strongly suggest that (1) common features in MDSs involving the TEL gene are monocytosis and eosinophilia, (2) chromosomes other than no. 5 may be involved and at least a t(10;12)(q24;p13) variant chromosome translocation does exist in these MDSs, and (3) both standard and variant 12p/TEL translocations may be identified by FISH with appropriate probes.

Volume 85, Issue 10, pp. 2848-2852, 05/15/1995
Copyright © 1995 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
C. Morerio, M. Acquila, C. Rosanda, A. Rapella, C. Dufour, F. Locatelli, E. Maserati, F. Pasquali, and C. Panarello
HCMOGT-1 Is a Novel Fusion Partner to PDGFRB in Juvenile Myelomonocytic Leukemia with t(5;17)(q33;p11.2)
Cancer Res., April 15, 2004; 64(8): 2649 - 2651.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Boccuni, D. MacGrogan, J. M. Scandura, and S. D. Nimer
The Human L(3)MBT Polycomb Group Protein Is a Transcriptional Repressor and Interacts Physically and Functionally with TEL (ETV6)
J. Biol. Chem., April 18, 2003; 278(17): 15412 - 15420.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
H. Hirai
Molecular Mechanisms of Myelodysplastic Syndrome
Jpn. J. Clin. Oncol., April 1, 2003; 33(4): 153 - 160.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
B. J. Bain
Eosinophilia -- Idiopathic or Not?
N. Engl. J. Med., October 7, 1999; 341(15): 1141 - 1143.
[Full Text]


Home page
BloodHome page
J. Cools, C. Bilhou-Nabera, I. Wlodarska, C. Cabrol, P. Talmant, P. Bernard, A. Hagemeijer, and P. Marynen
Fusion of a Novel Gene, BTL, to ETV6 in Acute Myeloid Leukemias With a t(4;12)(q11-q12;p13)
Blood, September 1, 1999; 94(5): 1820 - 1824.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Faderl, H. M. Kantarjian, M. Talpaz, and Z. Estrov
Clinical Significance of Cytogenetic Abnormalities in Adult Acute Lymphoblastic Leukemia
Blood, June 1, 1998; 91(11): 3995 - 4019.
[Full Text] [PDF]


Home page
BloodHome page
I. Wlodarska, R. La Starza, M. Baens, J. Dierlamm, A. Uyttebroeck, D. Selleslag, A. Francine, C. Mecucci, A. Hagemeijer, H. Van den Berghe, et al.
Fluorescence In Situ Hybridization Characterization of New Translocations Involving TEL (ETV6) in a Wide Spectrum of Hematologic Malignancies
Blood, February 15, 1998; 91(4): 1399 - 1406.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Sato, S. K. Bohlander, H. Kobayashi, S. Reshmi, Y. Suto, E. M. Davis, R. Espinosa III, R. Hoopes, K. T. Montgomery, R. S. Kucherlapati, et al.
Heterogeneity in the Breakpoints in Balanced Rearrangements Involving Band 12p13 in Hematologic Malignancies Identified by Fluorescence In Situ Hybridization: TEL (ETV6 ) Is Involved in Only One Half
Blood, December 15, 1997; 90(12): 4886 - 4893.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Abe, N. Emi, M. Tanimoto, H. Terasaki, T. Marunouchi, and H. Saito
Fusion of the Platelet-Derived Growth Factor Receptor beta  to a Novel Gene CEV14 in Acute Myelogenous Leukemia After Clonal Evolution
Blood, December 1, 1997; 90(11): 4271 - 4277.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S.C. Raimondi, S.A. Shurtleff, J.R. Downing, J. Rubnitz, S. Mathew, M. Hancock, C-H. Pui, G.K. Rivera, G.C. Grosveld, and F.G. Behm
12p Abnormalities and the TEL Gene (ETV6) in Childhood Acute Lymphoblastic Leukemia
Blood, December 1, 1997; 90(11): 4559 - 4566.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Peeters, S. D. Raynaud, J. Cools, I. Wlodarska, J. Grosgeorge, P. Philip, F. Monpoux, L. Van Rompaey, M. Baens, H. Van den Berghe, et al.
Fusion of TEL, the ETS-Variant Gene 6 (ETV6), to the Receptor-Associated Kinase JAK2 as a Result of t(9; 12) in a Lymphoid and t(9; 15; 12) in a Myeloid Leukemia
Blood, October 1, 1997; 90(7): 2535 - 2540.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Borkhardt, G. Cazzaniga, S. Viehmann, M. G. Valsecchi, W. D. Ludwig, L. Burci, S. Mangioni, M. Schrappe, H. Riehm, F. Lampert, et al.
Incidence and Clinical Relevance of TEL/AML1 Fusion Genes in Children With Acute Lymphoblastic Leukemia Enrolled in the German and Italian Multicenter Therapy Trials
Blood, July 15, 1997; 90(2): 571 - 577.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. B. Gorlin and J. A. Ferry
Case 26-1996- A Seven-Year-Old-Boy with Fever, Lymphadenopathy, Hepatosplenomegaly, and Prominent Eosinophilia
N. Engl. J. Med., August 22, 1996; 335(8): 577 - 584.
[Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1995 by American Society of Hematology         Online ISSN: 1528-0020